ArticleMethods in molecular biology (Clifton, N.J.)2025
Mouse Embryonic Fibroblasts Reprogramming to Induced Pluripotent Stem Cells by T3.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Somatic cells can be transformed into induced pluripotent stem cells (iPSCs) using a technique called reprogramming. This process involves introducing Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc) to the cells through retroviral supernatants. This chapter outlines a protocol for reprogramming mouse embryonic fibroblasts (MEFs) using the hormone triiodo-L-thyronine (T3) to enhance the generation of iPSCs. It also describes how to analyze these iPSCs by colony staining for alkaline phosphatase activity, a standard marker for identifying pluripotent embryonic stem cells. To further study iPSCs, individual colonies must be selected and expanded, and pluripotency is examined by analyzing gene expression profiles using quantitative real-time PCR to measure the endogenous expression of pluripotency genes. Integrating T3 into reprogramming methods may significantly improve the production of functional iPSCs. This advancement could open new avenues for research in cell plasticity, disease modeling, and regenerative therapies.
Indexed as
Identifiers
39579312What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.